EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lactobacillus reuteri DSM 17938 and Its Supernatant Ameliorate Parkinson’s Disease in Association with Modulation of Gut Microbiota and Its Tryptophan Metabolism

Bin Su iD, Fanying Meng iD, Yao Lu, Yunlong Zhang, Tingting Wang, Yuxin Zhang, Jiajia Liu iD, Lianbing Lin

Antioxidants · 16.07.2026 · 15 (7) · 882

DOI: 10.3390/antiox15070882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 16.07.2026. Verfasst von Bin Su und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Science and Technology Plan Special Project in Yunnan. Province, China, Major Science and Technology Plan Special Project in Yunnan Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is a neurodegenerative disorder associated with gut dysbiosis and tryptophan metabolism disturbance, but the mechanisms of probiotic action are unclear. We orally administered Lactobacillus reuteri DSM 17938 live bacteria (1.0 × 109 CFU/mL, 0.2 mL) or its fermentation supernatant lyophilized powder at three concentrations to MPTP-induced PD male C57BL/6J mice. Treatments increased locomotor distance and speed, elevated serum SOD and GSH, reduced MDA, TNF-α, IL-6, and IL-1β, promoted neuronal survival, and tended to increase TH expression in the substantia nigra. 16S rRNA sequencing showed that treatments altered gut microbiota composition. PD mice had increased Lactobacillus and Allobaculum but decreased Oscillospira and Helicobacter; treatments restored Oscillospira. Fecal untargeted metabolomics revealed disturbed tryptophan metabolism in PD, with elevated indoleacetic acid and reduced kynurenic acid, xanthurenic acid, indole-3-ethanol, and α-oxo-1H-indole-3-propanoic acid. Treatments significantly restored neuroprotective metabolites including kynurenic acid, xanthurenic acid, and serotonin. PICRUSt2 predicted tryptophan synthesis pathway-associated microbes (Oscillospira, Ruminococcus, Coprococcus). Treatments ameliorated motor deficits, oxidative stress, inflammation, and dopaminergic neuron death, correlating with gut microbiota modulation and accumulation of microbiota-derived tryptophan metabolites. Live bacteria showed superior antioxidant and neuroprotective efficacy compared to supernatant, likely due to sustained colonization and continuous metabolic activity. These findings suggest that targeting key tryptophan-metabolizing bacteria or their metabolites may be a potential PD therapy.

Schlagwörter

Stichwörter der Autor:innen

Lactobacillus reuteri DSM 17938Parkinson’s diseasegut microbiotamicrobial tryptophan metabolitesprobiotics

Autor:innen und Institutionen

  • Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China.
  • Engineering Research Center for Replacement Technology of Feed Antibiotics of Yunnan College, Kunming 650500, China.

ORCID-Profile: Bin Su, Fanying Meng, Jiajia Liu

Förderung

  • Major Science and Technology Plan Special Project in Yunnan. Province, China
  • Major Science and Technology Plan Special Project in Yunnan Province, China

Zitieren

APA

Su, B., Meng, F., Lu, Y., Zhang, Y., Wang, T., Zhang, Y., Liu, J., & Lin, L. (2026). Lactobacillus reuteri DSM 17938 and Its Supernatant Ameliorate Parkinson’s Disease in Association with Modulation of Gut Microbiota and Its Tryptophan Metabolism. Antioxidants, 15(7), 882. https://doi.org/10.3390/antiox15070882

Vancouver

Su B, Meng F, Lu Y, Zhang Y, Wang T, Zhang Y, et al. Lactobacillus reuteri DSM 17938 and Its Supernatant Ameliorate Parkinson’s Disease in Association with Modulation of Gut Microbiota and Its Tryptophan Metabolism. Antioxidants. 2026;15(7):882. doi:10.3390/antiox15070882

BibTeX
@article{Su2026,
  author = {Su, Bin and Meng, Fanying and Lu, Yao and Zhang, Yunlong and Wang, Tingting and Zhang, Yuxin and Liu, Jiajia and Lin, Lianbing},
  title = {Lactobacillus reuteri DSM 17938 and Its Supernatant Ameliorate Parkinson’s Disease in Association with Modulation of Gut Microbiota and Its Tryptophan Metabolism},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {882},
  doi = {10.3390/antiox15070882}
}
Kostenlos starten →